Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Minang Turakhia

Clinical Cardiac Electrophysiology Stanford, CA Medical Doctor

NPI 1528114204 CMS profile 250155

300 Pasteur Dr, Stanford, CA 94305

Open in the dashboard

General payments

$110,481

110 records reported · program years 2019–2025

Research payments

$2,250

Paid to them · 3 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$75,874 paid to institutions, not to them · program years 2019–2022

Through program year 2025, Minang Turakhia of Stanford, CA is reported in the CMS Open Payments database as having received $110,481 across 110 general payments and $2,250 in research payments paid to them. Separately, studies naming them as principal investigator received $75,874 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 89th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $60 2
2025 Research $1,250 1
2024 General $84 1
2023 General $4,500 2
2023 Research $1,000 2
2022 General $11,171 10
2021 General $35,526 29
2020 General $24,181 13
2019 General $34,960 53

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Minang Turakhia
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Minang Turakhia were reported at $60. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Minang Turakhia Clinical Cardiac Electrophysiology median Middle half National median
2019 $34,960 $2,361 $585–$8,260 $163
2020 $24,181 $993 $247–$4,351 $114
2021 $35,526 $1,185 $326–$4,739 $132
2022 $11,171 $2,073 $554–$6,789 $149
2023 $4,500 $2,568 $759–$8,159 $160
2024 $84 $2,557 $703–$7,403 $164
2025 $60 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. E.R. Squibb & Sons, L.L.C. $26,038 7 payments
  2. Sanofi-Aventis U.S. LLC $18,196 9 payments
  3. Novartis Pharmaceuticals Corporation $13,888 9 payments
  4. Pfizer Inc. $11,585 9 payments
  5. Medtronic, Inc. $10,936 24 payments
  6. Medtronic Vascular, Inc. $10,125 16 payments
  7. Abbott Laboratories $6,682 10 payments
  8. Bayer HealthCare Pharmaceuticals Inc. $6,330 2 payments
  9. Biotronik Inc. $4,262 6 payments
  10. Medical Device Business Services, Inc. $765 1 payment
  11. Other $1,674 17 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $73,022 29 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $23,050 10 payments
  3. Travel and Lodging $7,596 26 payments
  4. Grant $2,813 3 payments
  5. Food and Beverage $2,801 41 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $1,200 1 payment
Products named General payments · program years 2019–2025
  1. ELIQUIS Cardiovascular $20,900 5 payments
  2. MULTAQ Cardiology/Vascular Diseases $10,368 7 payments
  3. ELIQUIS Cardiovascular;Metabolic Disease $10,000 4 payments
  4. MULTAQ Cardiology/Vascular Diseases $7,828 2 payments
  5. ENTRESTO $5,680 2 payments
  6. Non-Covered $3,330 1 payment
  7. Fortify Assura, Ellipse ICD $2,086 3 payments
  8. HeartMate 3 Left Ventricular Dev $1,500 1 payment
  9. Confirm Rx $1,277 3 payments
  10. CardioMEMS HF System $1,200 1 payment
  11. Other $5,524 27 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Sanofi-Aventis U.S. LLC $2,250 3 payments

Records

113 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record